Clinical Trial Update: A Study of SHR-1918 In Participants With Hypertriglyceridemia [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating SHR-1918 for hypertriglyceridemia is planned. The trial is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• SHR-1918

Snippet

Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd | Conditions: Hypertriglyceridemia | Phase 3 | Status: NOT_YET_RECRUITING